Skip to main navigation Skip to search Skip to main content

Indolent lymphoma: addressing the needs of survivors

Pasquale L. Fedele, Stephen Opat

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Over the past two decades, there has been a continuous improvement in outcome for patients with indolent lymphoma (iNHL) resulting in a gradual accumulation of survivors. While life expectancy in the current era approaches that of the lymphoma-free population, patients continue to experience lifelong complications of the disease and its treatment affecting general health, emotional, psychological and social wellbeing, relationships, employment, finances, and fitness. Contemporary care models while suited to the management of lymphoma are often lacking when it comes to identification and management of these additional needs. Given improvements in physical survival achieved over the past decades, it is timely for us to focus on other issues affecting patient wellbeing including immunodeficiency and infection, second cancers, cardiovascular disease, bone health, psychological wellbeing, and sexual health. Many of these aspects are in the domain of the primary care physician; however, there is limited guidance on how these issues should be addressed. It is now time for us to engage our patients, their caregivers, and other healthcare providers in care aspects beyond the lymphoma diagnosis, so they can anticipate a rich and full life, free from both direct and indirect consequences of the lymphoma diagnosis.

Original languageEnglish
Pages (from-to)1021-1035
Number of pages15
JournalLeukemia and Lymphoma
Volume66
Issue number6
DOIs
Publication statusPublished - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chronic lymphocytic leukemia
  • CLL
  • follicular lymphoma
  • Indolent lymphoma
  • Lymphoplasmacytic lymphoma
  • Marginal zone lymphoma
  • survivorship care
  • Waldenström’s macroglobulinemia

Cite this